Prevention and Interception of Immune-Mediated Disease
Provention Bio targets the interception and prevention of immune-mediated disease. Unlike the conventional pharmaceutical approach, which is focused on the treatment of symptoms and complications of late-stage or end-stage disease, we aim to intervene in the underlying autoimmune process before a patient suffers long-term tissue damage… before it is too late.
Consistent with this perspective, we have built a carefully selected portfolio of candidates that target upstream pathways in T cell or B cell biology. Our therapeutic candidates each have the potential to interrupt, delay, reverse or prevent the onset or progression of a life-threatening or debilitating immune-mediated diseases, including type 1 diabetes, celiac disease, and lupus.